{{Distinguish|cyclopamine}}
{{Underlinked|date=October 2016}}
{{Drugbox
| IUPAC_name = ''N''-Methyl-2,3,7,8-tetrahydro-1''H''-quino[1,8-ab][1]benzazepin-3-amine
| image = Ciclopramine.svg
| width = 200

<!--Clinical data-->
| tradename =
| pregnancy_category =
| legal_status = Not marketed
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 33545-56-1
| ATC_prefix = None
| ATC_suffix =
| PubChem = 160410
| ChEMBL = 2105933
| ChemSpiderID = 140965
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = BXS8X8APGS

<!--Chemical data-->
| C=18 | H=20 | N=2 
| molecular_weight = 264.36 g/mol
| smiles = c14c2c(ccc1)C(NC)CCN2c3ccccc3CC4
}}

'''Ciclopramine''' is a [[tetracyclic antidepressant]] (TeCA) that was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | accessdate = }}</ref><ref name="pmid7090895">{{cite journal | author = Saletu B | title = Pharmaco-EEG profiles of typical and atypical antidepressants | journal = Advances in Biochemical Psychopharmacology | volume = 32 | issue = | pages = 257â€“68 | year = 1982 | pmid = 7090895 | doi = | url = }}</ref>

== References ==
{{Reflist}}

{{Antidepressants}}
{{Tricyclics}}

[[Category:Abandoned drugs]]
[[Category:Amines]]
[[Category:Tetracyclic antidepressants]]
[[Category:Dibenzazepines]]

{{nervous-system-drug-stub}}